Select Medical Holdings Corporation (SEM) Q4 2024 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q4 2024 Earnings Conference Call February 21, 2025 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Michael Malatesta - Executive Vice President and CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendricks - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter and Full Year 2024 Results and the Company's Business Outlook. Speaking today are the Company's Executive Chairman and Co-Founder, Robert Ortenzio; the Company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson; and Executive Vice President and CFO, Michael Malatesta.
Select Medical (SEM) Lags Q4 Earnings Estimates
Select Medical (SEM) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.36 per share a year ago.
SEM Plunges 48.2% in 6 Months: Should You Buy, Hold or Sell the Stock?
Rising expenses and high leverage are impacting Select Medical's prospects.
All You Need to Know About Select Medical (SEM) Rating Upgrade to Buy
Select Medical (SEM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
After Plunging -38.05% in 4 Weeks, Here's Why the Trend Might Reverse for Select Medical (SEM)
The heavy selling pressure might have exhausted for Select Medical (SEM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Select Medical Distributes Concentra Shares to Shareholders
By separating from Concentra, which specializes in occupational health services, SEM can better allocate resources to its primary segments.
Why Select Medical (SEM) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Investors Undervaluing Select Medical (SEM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical To Spin-Off Concentra On November 25th
On November 06, Select Medical Holdings (NYSE: SEM; $40.20; Market Cap: $5.2 billion) announced a special stock distribution of its carved out unit Concentra Holdings (NYSE: CON; $19.67; Market Cap: $2.5 billion) to its shareholders. The distribution is set for November 25, 2024, with a record date of November 18, 2024.
Select Medical Up 13.8% Since Q3 Earnings Top on Patient Day Growth
SEM's strong third-quarter results benefit from improving patient days and admissions in the Rehabilitation Hospital segment. Elevated expenses partially offset the positives.
Here's Why Select Medical (SEM) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Select Medical Holdings Corporation (SEM) Q3 2024 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q3 2024 Results Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Conference Call Participants Ben Hendrix - RBC Capital Markets Justin Bowers - Deutsche Bank William Sutherland - The Benchmark Company Christian Malachy Porter - Bank of America Securities Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to Discuss the Third Quarter 2024 Results and the Company's Business Outlook. Speaking today are the company's Executive Chairman and Co-Founder, Robert Ortenzio, and the company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson.
